glp-1 news october 1 2025 How FDA Crackdowns Are Affecting Use In RACGP - TGA issues GLP-1

ATTAIN-1 compared Foundayo to placebo, and found that patients lost approximately 11% of their bodyweight on the highest Foundayo doses

Regular monitoring of hydration and kidney function is recommended

Each treatment is performed by experienced professionals who use precise dosing for safe, visible results

I think we built medical specialties based on the complications of obesity. When you look at cardiology, nephrology, neurology, many of the diseases they treat share overlapping drivers

Rest assured this is a weight loss clinic worth visiting

Although the subjects were non-diabetic, one meaningful study observed acute changes of cardiovascular risk markers such as HR and BP upon intravenous administration of GLP-1 RA [38]